标题
Budesonide Multi-matrix for the Treatment of Patients with Ulcerative Colitis
作者
关键词
Budesonide MMX, Induction therapy, Remission, Ulcerative colitis
出版物
DIGESTIVE DISEASES AND SCIENCES
Volume 61, Issue 2, Pages 358-370
出版商
Springer Nature
发表日期
2015-11-05
DOI
10.1007/s10620-015-3897-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies
- (2015) W. J. Sandborn et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Su2080 Efficacy of Budesonide MMx(r) 6 mg QD for the Maintenance of Remission in Patients With Ulcerative Colitis: Results From a Phase III, 12 Month Safety and Extended use Study
- (2015) William J. Sandborn et al. GASTROENTEROLOGY
- Review article: integrating budesonide-MMX into treatment algorithms for mild-to-moderate ulcerative colitis
- (2014) S. Danese et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Case-control study of factors that trigger inflammatory bowel disease flares
- (2014) Linda A Feagins WORLD JOURNAL OF GASTROENTEROLOGY
- Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study
- (2013) Simon P L Travis et al. GUT
- Bioavailability profile of Uceris MMX extended-release tablets compared with Entocort EC capsules in healthy volunteers
- (2013) Andrew Nicholls et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Once-Daily MMX® Mesalamine for Endoscopic Maintenance of Remission of Ulcerative Colitis
- (2012) Geert D'Haens et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis
- (2012) Debanjali Mitra et al. BMC GASTROENTEROLOGY
- Direct Health Care Insurer and Out-of-Pocket Expenditures of Inflammatory Bowel Disease: Evidence from a US National Survey
- (2012) Candace Gunnarsson et al. DIGESTIVE DISEASES AND SCIENCES
- Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study
- (2012) William J. Sandborn et al. GASTROENTEROLOGY
- Induction of remission with oral budesonide MMX® (9 mg) tablets in oatients with mild to moderate, active Ulcerative Colitis: A multicenter, open-label efficacy and safety study
- (2012) Simon Travis et al. INFLAMMATORY BOWEL DISEASES
- Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
- (2012) Axel Dignass et al. Journal of Crohns & Colitis
- Ulcerative colitis
- (2012) Ingrid Ordás et al. LANCET
- The burden of inflammatory bowel disease on health care utilization and quality of life
- (2012) Ellinoora Nurmi et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
- (2011) Natalie A. Molodecky et al. GASTROENTEROLOGY
- Cost Effectiveness of Treatments for Inflammatory Bowel Disease
- (2011) Keith Bodger PHARMACOECONOMICS
- Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
- (2010) Asher Kornbluth et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- New Drug Delivery Systems in Inflammatory Bowel Disease: MMX™ and Tailored Delivery to the Gut
- (2010) G. Fiorino et al. CURRENT MEDICINAL CHEMISTRY
- Oral budesonide for maintenance of remission of Crohn’s disease: a pooled safety analysis
- (2008) G. R. LICHTENSTEIN et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Immunosuppressant Medications and Mortality in Inflammatory Bowel Disease
- (2008) James D. Lewis et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Direct Health Care Costs of Crohn's Disease and Ulcerative Colitis in US Children and Adults
- (2008) Michael D. Kappelman et al. GASTROENTEROLOGY
- Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis
- (2008) M A Kamm et al. GUT
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More